147 related articles for article (PubMed ID: 20349266)
1. Rapid recurrence of craniopharyngioma following recombinant human growth hormone replacement.
Taguchi T; Takao T; Iwasaki Y; Pooh K; Okazaki M; Hashimoto K; Terada Y
J Neurooncol; 2010 Nov; 100(2):321-2. PubMed ID: 20349266
[No Abstract] [Full Text] [Related]
2. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
3. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
4. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
5. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous reduction of a recurrent craniopharyngioma in an 8-year-old female patient: case report.
Shinohara O; Shinagawa T; Kubota C; Oi S
Neurosurgery; 1997 Nov; 41(5):1188-90. PubMed ID: 9361075
[TBL] [Abstract][Full Text] [Related]
7. 'Disappearing' recurrent craniopharyngioma.
Murphy M; Worth RD; Norris JS
Br J Neurosurg; 2004 Feb; 18(1):65. PubMed ID: 15040718
[No Abstract] [Full Text] [Related]
8. Ectopic recurrence of craniopharyngioma.
Kawaguchi T; Fujimura M; Shirane R; Shoji T; Watanabe M; Tominaga T
J Clin Neurosci; 2005 Apr; 12(3):307-9. PubMed ID: 15851090
[TBL] [Abstract][Full Text] [Related]
9. Ectopic craniopharyngioma.
Kordes U; Flitsch J; Hagel C; Goebell E; Schwarz R; Herberhold T; von Bueren AO; Rutkowski S; Müller HL
Klin Padiatr; 2011 May; 223(3):176-7. PubMed ID: 21462099
[No Abstract] [Full Text] [Related]
10. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
[TBL] [Abstract][Full Text] [Related]
12. Metastatic craniopharyngioma.
Gupta K; Kuhn MJ; Shevlin DW; Wacaser LE
AJNR Am J Neuroradiol; 1999; 20(6):1059-60. PubMed ID: 10445444
[TBL] [Abstract][Full Text] [Related]
13. A rare case of ectopic recurrence of a craniopharyngioma diagnosed 17 years after initial presentation.
de Blank PM; Minturn JE
J Pediatr Hematol Oncol; 2011 Jul; 33(5):392-7. PubMed ID: 21602726
[TBL] [Abstract][Full Text] [Related]
14. Postoperative ectopic seeding of craniopharyngioma. Case illustration.
Lee JH; Kim CY; Kim DG; Jung HW
J Neurosurg; 1999 Apr; 90(4):796. PubMed ID: 10193630
[No Abstract] [Full Text] [Related]
15. Rapid recurrence of craniopharyngioma during pregnancy with recovery of vision: a case report.
Maniker AH; Krieger AJ
Surg Neurol; 1996 Apr; 45(4):324-7. PubMed ID: 8607079
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation in craniopharyngioma.
Nelson GA; Bastian FO; Schlitt M; White RL
Neurosurgery; 1988 Feb; 22(2):427-9. PubMed ID: 3352897
[TBL] [Abstract][Full Text] [Related]
17. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
Niu DM; Guo WY; Pan HC; Wong TT
Childs Nerv Syst; 2002 Apr; 18(3-4):164-5. PubMed ID: 11981627
[TBL] [Abstract][Full Text] [Related]
18. Craniopharyngioma with extension into the cerebellopontine angle. Case report.
Shimada M; Tsugane R; Shibuya N; Sato O
Tokai J Exp Clin Med; 1989 Apr; 14(2):113-6. PubMed ID: 2700606
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy in the management of craniopharyngioma: current concepts and future developments.
Habrand JL; Saran F; Alapetite C; Noel G; El Boustany R; Grill J
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():389-94. PubMed ID: 16700315
[No Abstract] [Full Text] [Related]
20. Craniopharyngioma recurrence and growth hormone therapy.
Clayton PE; Price DA; Shalet SM; Gattemaneni HR
Lancet; 1988 Mar; 1(8586):642. PubMed ID: 2894566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
